Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques

Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques
复制标题

DOI:
10.1016/j.fertnstert.2004.06.041
复制
发表时间:
2004-12-01
影响因子:
6.7
通讯作者:
Montanaro, N
Montanaro, N
中科院分区:
医学2区
文献类型:
--
作者:
Ferraretti, AP;Gianaroli, L;Montanaro, N

文献摘要

被引文献

相似文献

目的:为探讨外源性促性腺激素(LH)在控制性超促排卵中的作用,采用前瞻性随机对照研究方法,将在促性腺激素释放激素(GnRH)下调下对FSH低反应的妇女随机分为3组:A组(n = 54),增加FSH剂量; B组(n = 54)在增加FSH剂量的基础上加用重组LH,C组(n = 22)在增加FSH和LH的基础上加用hMG。54例年龄匹配的无需增加FSH剂量的妇女作为对照组(D)。干预措施:无。主要结局指标:每个开始周期的着床率和活产率。结果:与A组和C组相比,B组的妊娠率和着床率在统计学上较高,与正常反应的对照组相比无差异。B组和D组的活产率相似,但A组和C组的活产率为A组和C组的一半。结论:对FSH的低反应性可能与医源性LH缺乏有关,医源性LH缺乏反过来会影响卵母细胞的能力。添加少量重组LH能够挽救卵母细胞产生可存活胚胎的能力。(C)2004年,美国生殖医学会。
Objective: To investigate the role of exogenous LH in controlled ovarian hyperstimulation for assisted reproductive technologies.Design: Prospective randomized study.Setting: SISMER fertility unit.Patient(s): Women showing a hyporesponsiveness to FSH under GnRH agoinst down-regulation were randomized into three groups: group A (n = 54) received an increased dosage of FSH; group B (n = 54) was administered recombinant LH in addition to the increased dose of FSH; group C (n = 22) was given additional FSH and LH using hMG as a combined drug. Fifty-four age-matched women with no need to increase the FSH dose were included as a control group (D).Intervention(s): None.Main Outcome Measure(s): Implantation and live birth rate per started cycles.Result(s): In group B, the pregnancy and implantation rates were statistically higher when compared with groups A and C and did not differ from the control group for normal response. The live birth rate was similar in groups B and D but was half as high in groups A and C.Conclusion(s): Hyporesponsiveness to FSH could be related to iatrogenic LH deficiency that, in turn, could affect oocyte competence. Addition of a small amount of recombinant LH is able to rescue oocyte competence to produce viable embryos. (C) 2004 by American Society for Reproductive Medicine.